Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 12, Issue 11, Pages 1333-1341
Publisher
Informa UK Limited
Online
2016-07-18
DOI
10.1080/17425255.2016.1214714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype
- (2016) T. Kagami et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The binding selectivity of vonoprazan (TAK-438) to the gastric H+,K+-ATPase
- (2015) D. R. Scott et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
- (2015) H. Jenkins et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
- (2015) K. Ashida et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study
- (2015) Y. Sakurai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
- (2015) Yuuichi Sakurai et al. Clinical and Translational Gastroenterology
- Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
- (2014) Ralph-Steven Wedemeyer et al. DRUG SAFETY
- EAES recommendations for the management of gastroesophageal reflux disease
- (2014) Karl Hermann Fuchs et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
- (2013) John Dent et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of long-term PPI therapy
- (2013) Christina Reimer BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The pharmacokinetics of ilaprazole for gastro-esophageal reflux treatment
- (2013) Nicola de Bortoli et al. Expert Opinion on Drug Metabolism & Toxicology
- Novel Pharmaceutical Approaches to Reflux Disease
- (2013) Usha Dutta et al. GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
- (2013) Hashem B El-Serag et al. GUT
- Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
- (2013) N. de Bortoli et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome
- (2013) Nicola de Bortoli WORLD JOURNAL OF GASTROENTEROLOGY
- Optimal treatment of laryngopharyngeal reflux disease
- (2013) Irene Martinucci et al. Therapeutic Advances in Chronic Disease
- Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors
- (2012) Daniel Sifrim et al. GUT
- Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB)
- (2012) Yasuyoshi Arikawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
- (2012) Nicola de Bortoli WORLD JOURNAL OF GASTROENTEROLOGY
- Barrett's esophagus: proton pump inhibitors and chemoprevention II
- (2011) Joel E. Richter et al. Annals of the New York Academy of Sciences
- A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands
- (2011) Jun Matsukawa et al. BIOCHEMICAL PHARMACOLOGY
- Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD
- (2011) Jean-Paul Galmiche et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Study Comparing the Antisecretory Effect of TAK-438, a Novel Potassium-Competitive Acid Blocker, with Lansoprazole in Animals
- (2011) Y. Hori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The role and limitations of H2-receptor antagonist in the treatment of gastro-oesophageal refrux disease
- (2010) D. G. COLIN-JONES ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The refluxate: The impact of its magnitude, composition and distribution
- (2010) Philip Woodland et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Short and long-term PPI treatment for GERD. Do we need more-potent anti-secretory drugs?
- (2010) Stanislas Bruley des Varannes et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors
- (2010) Tiberiu Hershcovici et al. CURRENT OPINION IN GASTROENTEROLOGY
- Clinical trial: Inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects
- (2010) Hyung-Keun Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases
- (2010) Y. Hori et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characteristics of gastro-esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers
- (2010) E. Savarino et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Management of heartburn not responding to proton pump inhibitors
- (2009) R Fass et al. GUT
- Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus
- (2008) G H Koek et al. GUT
- Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety
- (2008) Vincenzo Savarino et al. PHARMACOLOGICAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started